Page last updated: 2024-08-24

zanamivir and rimantadine

zanamivir has been researched along with rimantadine in 73 studies

Research

Studies (73)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	6 (8.22)	18.2507
2000's	50 (68.49)	29.6817
2010's	15 (20.55)	24.3611
2020's	2 (2.74)	2.80

Authors

Authors	Studies
Batta, G; Bereczki, I; Borbás, A; Fejes, Z; Herczegh, P; Kiss-Szikszai, A; Naesens, L; Ostorházi, E; Rőth, E; Rozgonyi, F; Sipos, A; Török, Z	1
Cesur, N; Cesur, Z; Göktaş, F; Naesens, L; Vanderlinden, E	1
Fernández, R; Font-Bardia, M; Miquet, S; Naesens, L; Torres, E; Vanderlinden, E; Vázquez, S	1
Batta, G; Bereczki, I; Borbás, A; Dobray, L; Herczegh, P; Kéki, S; Kicsák, M; Naesens, L; Nikodém, ÉN; Ostorházi, E; Rozgonyi, F; Vanderlinden, E	1
Cichero, E; Costi, MP; Gazzarrini, S; Loddo, R; Moroni, A; Naesens, L; Santucci, M; Tasso, B; Tonelli, M	1
Cichero, E; Costi, MP; Francesconi, V; Giordanetto, F; Giovannini, L; Naesens, L; Santucci, M; Tonelli, M	1
Batta, G; Borbás, A; Csávás, M; Herczegh, P; Kelemen, V; Le Thai, S; Naesens, L; Rőth, E; Stevaert, A; Szűcs, Z; Vanderlinden, E	1
Andrei, G; Cazin, I; Harej, A; Klobučar, M; Macan, AM; Pavelić, K; Pavelić, SK; Raić-Malić, S; Schols, D; Snoeck, R; Stepanić, V	1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Hayden, FG; Madren, LK; Rollins, BS	1
Couch, RB	2
Ambrozaitis, A; Drinka, P; Gravenstein, M; Gravenstein, S; Jones, HH; Krause, P; Povinelli, L; Powers, D; Schilling, M; Shult, P	1
Mossad, SB	2
Silagy, CA	1
Deeks, J; Demicheli, V; Jefferson, T; Rivetti, D	1
Goldman, MP; Long, JK; Mossad, SB	1
Ashley, JV; Gum, KD; Montalto, NJ	1
Rosen, DS	1
Hayden, FG	2
Fleming, DM	1
Preboth, M	1
Holdiness, MR	1
Gross, PA	1
Farr, BM; Hall, KK; Hayden, FG; Salgado, CD	1
Bridges, CB; Cox, NJ; Fukuda, K; Singleton, JA; Uyeki, TM	1
Prober, CG	1
Englund, JA	1
Leong, MA; Simmen, KA; Wagaman, PC	1
Clements, DA; Hamilton, JD; Huber, J; Lee, PY; Matchar, DB; Peterson, ED	1
Davidson, HE; Gravenstein, S	1
Uyeki, T; Winquist, A	1
Dumyati, G; Falsey, AR	1
Balasingam, S; Bossuyt, S; Lambkin, R; Mann, A; Novelli, P; Oxford, JS	1
Mitamura, K	1
Kirkbride, HA; Watson, J	1
Elliott, M; Gnann, JW; Hayden, FG; Ison, MG; Nagy-Agren, S; Paya, C; Steigbigel, R; Treannor, J; Weiss, HL	1
Bellantonio, S; Rose, DN; Rothberg, MB	1
Pegram, PS; Williamson, JC	1
Lu, Q	1
Härtl, A; Sauerbrei, A; Stelzner, A; Wutzler, P	1
Fagan, HB; Moeller, AH	1
Hansen, L	2
Fang, HB; Govorkova, EA; Tan, M; Webster, RG	1
Brandstaedt, A; Haertl, A; Sauerbrei, A; Schmidtke, M; Wutzler, P	1
Barr, IG; Deed, N; Hurt, AC; Iannello, P; Komadina, N; Tomasov, C	1
Hayden, FG; Pavia, AT	1
Brydak, LB; Gawryluk, D; Machała, M; Wiatr, E	1
Lynch, JP; Walsh, EE	1
Cummings, JE; Kelly, EB; Raimer, SS; Snyder, RR	1
Wesseling, G	1
Worrall, G	1
Nüesch, R	1
Monto, AS	1
Balish, A; Bright, RA; Deyde, VM; Gubareva, LV; Klimov, AI; Lindstrom, S; Nguyen, T; Shu, B	1
Jefferson, T	1
Oxford, JS	1
Barr, IG; Holien, JK; Hurt, AC; Parker, MW	1
Beekmann, SE; Dharan, NJ; Finelli, L; Fiore, A; Fry, AM; Polgreen, PM; Uyeki, TM	1
Li, JF; Shen, JS; Xiong, RS; Zhang, Q; Zhao, QJ	1
Arnold, K; Baumbach, J; Bennett, NM; Doshi, S; Finelli, L; Fry, AM; Gershman, K; Hancock, EB; Kamimoto, L; Lynfield, R; Morin, C; Perez, A; Reingold, A; Ryan, P; Schaffner, W; Thomas, A; Yousey-Hindes, K; Zansky, S	1
Akl, EA; Alonso-Coello, P; Brozek, J; Chen, YL; Cheung, A; Flottorp, SA; Hopkins, JP; Hovhannisyan, G; Hsu, J; Ivanova, L; Mustafa, R; Saeterdal, I; Santesso, N; Schünemann, HJ; Smaill, F; Tian, J; Uyeki, TM; Wong, AD	1
Król, E; Rychłowska, M; Szewczyk, B	1
Li, F; Ma, C; Wang, J	1
Atkins, E; Bao, P; Barclay, WS; Bentham, M; Claridge, JK; Cook, GP; Elderfield, R; Evans, S; Foster, R; Foster, TL; Goldhill, DH; Griffin, S; Kankanala, J; Loundras, E; McKimmie, CS; Pingen, M; Schnell, JR; Scott, C; Simmons, K; Stilwell, PR; Targett-Adams, P; Tathineni, R; Thompson, J	1

Reviews

34 review(s) available for zanamivir and rimantadine

Article	Year
Underused options for preventing and treating influenza. Cleveland Clinic journal of medicine, 1999, Volume: 66, Issue:1 Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Drug Administration Routes; Female; Guanidines; Humans; Influenza Vaccines; Influenza, Human; Male; Middle Aged; Orthomyxoviridae; Pyrans; Ribavirin; Rimantadine; Sialic Acids; Zanamivir	1999
Prevention and early treatment of influenza in healthy adults. Vaccine, 2000, Jan-06, Volume: 18, Issue:11-12 Topics: Adolescent; Adult; Amantadine; Antiviral Agents; Cost-Benefit Analysis; Guanidines; Humans; Influenza Vaccines; Influenza, Human; Middle Aged; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2000
Measures for control of influenza. PharmacoEconomics, 1999, Volume: 16 Suppl 1 Topics: Amantadine; Amines; Antiviral Agents; Enzyme Inhibitors; Guanidines; Humans; Influenza A virus; Influenza Vaccines; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir	1999
Antiviral agents for treating influenza. Cleveland Clinic journal of medicine, 2000, Volume: 67, Issue:2 Topics: Acetamides; Amantadine; Antiviral Agents; Drug Administration Schedule; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2000
Updated treatment for influenza A and B. American family physician, 2000, Dec-01, Volume: 62, Issue:11 Topics: Acetamides; Amantadine; Antiviral Agents; Clinical Trials as Topic; Enzyme Inhibitors; Guanidines; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Treatment Outcome; Zanamivir	2000
Influenza virus and rhinovirus-related otitis media: potential for antiviral intervention. Vaccine, 2000, Dec-08, Volume: 19 Suppl 1 Topics: Acetamides; Adult; Anti-Bacterial Agents; Antiviral Agents; Child; Child, Preschool; Clinical Trials as Topic; Eustachian Tube; Guanidines; Humans; Infant; Influenza A virus; Influenza B virus; Influenza, Human; Interferon-beta; Oseltamivir; Otitis Media; Otitis Media with Effusion; Picornaviridae Infections; Piperidines; Pressure; Pyrans; Pyridazines; Respiratory Tract Infections; Rhinovirus; Rimantadine; Sialic Acids; Superinfection; Virus Replication; Zanamivir	2000
Managing influenza: amantadine, rimantadine and beyond. International journal of clinical practice, 2001, Volume: 55, Issue:3 Topics: Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Guanidines; Humans; Infant; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Middle Aged; Neuraminidase; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2001
Adverse cutaneous reactions to influenza vaccinations and chemotherapy. International journal of dermatology, 2001, Volume: 40, Issue:7 Topics: Acetamides; Amantadine; Antiviral Agents; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; Guanidines; Humans; Influenza Vaccines; Influenza, Human; Orthomyxoviridae; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Skin; Zanamivir	2001
Vaccines for pneumonia and new antiviral therapies. The Medical clinics of North America, 2001, Volume: 85, Issue:6 Topics: Acetamides; Adult; Aged; Amantadine; Antiviral Agents; Centers for Medicare and Medicaid Services, U.S.; Child; Global Health; Guanidines; Health Priorities; Humans; Incidence; Influenza Vaccines; Joint Commission on Accreditation of Healthcare Organizations; Morbidity; Neuraminidase; Oseltamivir; Patient Selection; Pneumococcal Vaccines; Pneumonia; Primary Prevention; Pyrans; Rimantadine; Safety; Sialic Acids; United States; Vaccination; Zanamivir	2001
Perspectives on antiviral use during pandemic influenza. Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2001, Dec-29, Volume: 356, Issue:1416 Topics: Acetamides; Amantadine; Antiviral Agents; Chemoprevention; Disease Outbreaks; Drug Resistance, Multiple, Viral; Drug Tolerance; Guanidines; Humans; Influenza A virus; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2001
Influenza in the acute hospital setting. The Lancet. Infectious diseases, 2002, Volume: 2, Issue:3 Topics: Acetamides; Amantadine; Antiviral Agents; Cross Infection; Disease Outbreaks; Guanidines; Hospitals; Humans; Influenza Vaccines; Influenza, Human; Nursing Staff, Hospital; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Vaccination; Virginia; Zanamivir	2002
Antiviral therapy for influenza virus infections. Seminars in pediatric infectious diseases, 2002, Volume: 13, Issue:1 Topics: Acetamides; Age Factors; Amantadine; Antiviral Agents; Child; Clinical Trials as Topic; Global Health; Guanidines; Humans; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2002
Antiviral therapy of influenza. Seminars in pediatric infectious diseases, 2002, Volume: 13, Issue:2 Topics: Acetamides; Administration, Inhalation; Administration, Oral; Adult; Amantadine; Antiviral Agents; Child; Drug Resistance, Viral; Guanidines; Humans; Infant; Influenza, Human; Orthomyxoviridae; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2002
Influenza. Clinical evidence, 2002, Issue:7 Topics: Acetamides; Administration, Inhalation; Administration, Oral; Adult; Amantadine; Antiviral Agents; Child; Guanidines; Humans; Influenza, Human; Oseltamivir; Pyrans; Randomized Controlled Trials as Topic; Rimantadine; Sialic Acids; Treatment Outcome; Zanamivir	2002
Antivirals for influenza: what is their role in the older patient? Drugs & aging, 2002, Volume: 19, Issue:10 Topics: Acetamides; Aged; Amantadine; Antiviral Agents; Drug Resistance, Viral; Guanidines; Humans; Influenza, Human; Oseltamivir; Practice Guidelines as Topic; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2002
Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2003, Volume: 9, Issue:1 Topics: Acetamides; Amantadine; Antiviral Agents; Clinical Trials as Topic; Disease Outbreaks; Endemic Diseases; Enzyme Inhibitors; Guanidines; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Viral Matrix Proteins; Zanamivir	2003
[Antiviral agents for influenza]. Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 2 Topics: Acetamides; Age Factors; Amantadine; Antiviral Agents; Drug Resistance, Viral; Guanidines; Humans; Influenza A virus; Influenza, Human; Neuraminidase; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Viral Matrix Proteins; Zanamivir	2003
Review of the use of neuraminidase inhibitors for prophylaxis of influenza. Communicable disease and public health, 2003, Volume: 6, Issue:2 Topics: Acetamides; Amantadine; Antiviral Agents; Enzyme Inhibitors; Guanidines; Health Planning; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Practice Guidelines as Topic; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2003
Neuraminidase inhibitors in patients with underlying airways disease. American journal of respiratory medicine : drugs, devices, and other interventions, 2002, Volume: 1, Issue:2 Topics: Acetamides; Amantadine; Antiviral Agents; Asthma; Bronchial Spasm; Comorbidity; Guanidines; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Product Surveillance, Postmarketing; Pulmonary Disease, Chronic Obstructive; Pyrans; Rimantadine; Risk Factors; Sialic Acids; Zanamivir	2002
What is the best antiviral agent for influenza infection? American family physician, 2004, Oct-01, Volume: 70, Issue:7 Topics: Acetamides; Administration, Oral; Adult; Amantadine; Antiviral Agents; Child; Contraindications; Evidence-Based Medicine; Family Practice; Guanidines; Humans; Influenza A virus; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2004
Influenza. Clinical evidence, 2003, Issue:10 Topics: Acetamides; Adult; Amantadine; Antiviral Agents; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2003
Influenza. Clinical evidence, 2004, Issue:12 Topics: Acetamides; Adult; Amantadine; Antiviral Agents; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2004
Which agents should we use to treat and prevent influenza in 2006-2007? Cleveland Clinic journal of medicine, 2006, Volume: 73, Issue:11 Topics: Amantadine; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza, Human; Neuraminidase; Oseltamivir; Rimantadine; Zanamivir	2006
Antiviral therapy and prophylaxis for influenza in children. Pediatrics, 2007, Volume: 119, Issue:4 Topics: Adamantane; Amantadine; Antiviral Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant; Influenza, Human; Male; Oseltamivir; Primary Prevention; Prospective Studies; Randomized Controlled Trials as Topic; Rimantadine; Risk Assessment; Severity of Illness Index; Treatment Outcome; Zanamivir	2007
Influenza: evolving strategies in treatment and prevention. Seminars in respiratory and critical care medicine, 2007, Volume: 28, Issue:2 Topics: Aged; Amantadine; Antiviral Agents; Centers for Disease Control and Prevention, U.S.; Child, Preschool; Humans; Infant; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Oseltamivir; Practice Guidelines as Topic; Ribavirin; Rimantadine; United States; Zanamivir	2007
Occasional review: influenza in COPD: pathogenesis, prevention, and treatment. International journal of chronic obstructive pulmonary disease, 2007, Volume: 2, Issue:1 Topics: Amantadine; Antiviral Agents; Humans; Influenza Vaccines; Influenza, Human; Oseltamivir; Pulmonary Disease, Chronic Obstructive; Rimantadine; Zanamivir	2007
[Antiviral treatment of influenza in humans]. Therapeutische Umschau. Revue therapeutique, 2007, Volume: 64, Issue:11 Topics: Amantadine; Animals; Antiviral Agents; Clinical Trials as Topic; Disease Outbreaks; Drug Resistance, Viral; Humans; Influenza A virus; Influenza, Human; Neuraminidase; Oseltamivir; Rimantadine; Virus Replication; Virus Shedding; Zanamivir	2007
Influenza. BMJ clinical evidence, 2009, Mar-12, Volume: 2009 Topics: Acute Disease; Administration, Inhalation; Humans; Incidence; Influenza Vaccines; Influenza, Human; Oseltamivir; Rimantadine; Zanamivir	2009
Antivirals for the treatment and prevention of epidemic and pandemic influenza. Influenza and other respiratory viruses, 2007, Volume: 1, Issue:1 Topics: Amantadine; Antiviral Agents; Chemoprevention; Disease Outbreaks; Drug Resistance, Viral; Humans; Influenza, Human; Oseltamivir; Rimantadine; Zanamivir	2007
[Research progress of anti-influenza virus agents]. Yao xue xue bao = Acta pharmaceutica Sinica, 2010, Volume: 45, Issue:3 Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Cyclopentanes; Guanidines; Humans; Indoles; Influenza, Human; Neuraminidase; Orthomyxoviridae; Oseltamivir; Pyrrolidines; Rimantadine; Structure-Activity Relationship; Viral Matrix Proteins; Zanamivir	2010
Antiviral drugs for influenza. The Medical letter on drugs and therapeutics, 2012, Jan-09, Volume: 54, Issue:1381 Topics: Adult; Amantadine; Antiviral Agents; Child; Female; Humans; Influenza Vaccines; Influenza, Human; Neuraminidase; Oseltamivir; Pregnancy; Rimantadine; Zanamivir	2012
Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. Annals of internal medicine, 2012, Apr-03, Volume: 156, Issue:7 Topics: Administration, Inhalation; Administration, Oral; Amantadine; Antiviral Agents; Confounding Factors, Epidemiologic; Hospitalization; Humans; Influenza, Human; Oseltamivir; Rimantadine; Treatment Outcome; Zanamivir	2012
Antivirals--current trends in fighting influenza. Acta biochimica Polonica, 2014, Volume: 61, Issue:3 Topics: Amantadine; Antiviral Agents; Disease Outbreaks; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Influenza A virus; Influenza, Human; Neuraminidase; Oseltamivir; Rimantadine; Viral Matrix Proteins; Zanamivir	2014
Inhibitors targeting the influenza virus hemagglutinin. Current medicinal chemistry, 2015, Volume: 22, Issue:11 Topics: Amantadine; Antiviral Agents; Enzyme Inhibitors; Hemagglutinin Glycoproteins, Influenza Virus; Neuraminidase; Orthomyxoviridae; Oseltamivir; Rimantadine; Zanamivir	2015

Trials

2 trial(s) available for zanamivir and rimantadine

Article	Year
Efficacy of zanamivir for chemoprophylaxis of nursing home influenza outbreaks. Vaccine, 1998, Volume: 16, Issue:18 Topics: Aged; Antiviral Agents; Disease Outbreaks; Female; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Male; Nursing Homes; Prospective Studies; Pyrans; Random Allocation; Rimantadine; Sialic Acids; Treatment Outcome; Wisconsin; Zanamivir	1998
Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza. Antiviral therapy, 2003, Volume: 8, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Double-Blind Method; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanidines; Humans; Influenza, Human; Male; Middle Aged; Nebulizers and Vaporizers; Pyrans; Respiratory Therapy; Rimantadine; Sialic Acids; Zanamivir	2003

Article

Year

Efficacy of zanamivir for chemoprophylaxis of nursing home influenza outbreaks.

Vaccine, 1998, Volume: 16, Issue:18

Topics: Aged; Antiviral Agents; Disease Outbreaks; Female; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Male; Nursing Homes; Prospective Studies; Pyrans; Random Allocation; Rimantadine; Sialic Acids; Treatment Outcome; Wisconsin; Zanamivir

1998

Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza.

Antiviral therapy, 2003, Volume: 8, Issue:3

Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Double-Blind Method; Drug Resistance, Viral; Drug Therapy, Combination; Female; Guanidines; Humans; Influenza, Human; Male; Middle Aged; Nebulizers and Vaporizers; Pyrans; Respiratory Therapy; Rimantadine; Sialic Acids; Zanamivir

2003

Other Studies

37 other study(ies) available for zanamivir and rimantadine

Article	Year
Synthesis of isoindole and benzoisoindole derivatives of teicoplanin pseudoaglycon with remarkable antibacterial and antiviral activities. Bioorganic & medicinal chemistry letters, 2012, Dec-01, Volume: 22, Issue:23 Topics: Anti-Bacterial Agents; Antiviral Agents; Cell Line; Cell Survival; Drug Resistance, Viral; Gram-Positive Bacteria; Herpesvirus 1, Human; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Isoindoles; Microbial Sensitivity Tests; o-Phthalaldehyde; Teicoplanin	2012
Microwave assisted synthesis and anti-influenza virus activity of 1-adamantyl substituted N-(1-thia-4-azaspiro[4.5]decan-4-yl)carboxamide derivatives. Bioorganic & medicinal chemistry, 2012, Dec-15, Volume: 20, Issue:24 Topics: Adamantane; Amides; Animals; Antiviral Agents; Aza Compounds; Chickens; Dogs; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Madin Darby Canine Kidney Cells; Microwaves; Orthomyxoviridae; Spiro Compounds; Structure-Activity Relationship; Virus Replication	2012
Synthesis and Anti-influenza A Virus Activity of 2,2-Dialkylamantadines and Related Compounds. ACS medicinal chemistry letters, 2012, Dec-13, Volume: 3, Issue:12 Topics:	2012
Semisynthetic teicoplanin derivatives as new influenza virus binding inhibitors: synthesis and antiviral studies. Bioorganic & medicinal chemistry letters, 2014, Aug-01, Volume: 24, Issue:15 Topics: Animals; Antiviral Agents; Binding Sites; Dogs; Dose-Response Relationship, Drug; Lipid Bilayers; Madin Darby Canine Kidney Cells; Microbial Sensitivity Tests; Molecular Structure; Orthomyxoviridae; Structure-Activity Relationship; Teicoplanin	2014
Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus. European journal of medicinal chemistry, 2017, Jul-28, Volume: 135 Topics: Antiviral Agents; Crystallography, X-Ray; Dose-Response Relationship, Drug; Folic Acid Antagonists; Humans; Influenza A Virus, H1N1 Subtype; Influenza B virus; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Proguanil; Respiratory Syncytial Viruses; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Triazines	2017
Synthesis, biological evaluation and molecular modeling of novel azaspiro dihydrotriazines as influenza virus inhibitors targeting the host factor dihydrofolate reductase (DHFR). European journal of medicinal chemistry, 2018, Jul-15, Volume: 155 Topics: Antiviral Agents; Aza Compounds; Dose-Response Relationship, Drug; Folic Acid Antagonists; Models, Molecular; Molecular Structure; Orthomyxoviridae; Spiro Compounds; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Triazines	2018
Structure-activity relationship studies of lipophilic teicoplanin pseudoaglycon derivatives as new anti-influenza virus agents. European journal of medicinal chemistry, 2018, Sep-05, Volume: 157 Topics: Antiviral Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Humans; Influenza A virus; Influenza B virus; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Teicoplanin	2018
Antitumor and antiviral activities of 4-substituted 1,2,3-triazolyl-2,3-dibenzyl-L-ascorbic acid derivatives. European journal of medicinal chemistry, 2019, Dec-15, Volume: 184 Topics: Antineoplastic Agents; Antiviral Agents; Apoptosis; Ascorbic Acid; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles; Viruses	2019
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
Anti-influenza virus activity of the neuraminidase inhibitor 4-guanidino-Neu5Ac2en in cell culture and in human respiratory epithelium. Antiviral research, 1994, Volume: 25, Issue:2 Topics: Animals; Antiviral Agents; Cell Line; Dogs; Epithelium; Guanidines; Humans; Influenza A virus; Influenza B virus; Kidney; Neuraminidase; Organ Culture Techniques; Pyrans; Respiratory System; Ribavirin; Rimantadine; Sialic Acids; Virus Replication; Zanamivir	1994
A new antiviral agent for influenza--is there a clinical niche? The New England journal of medicine, 1997, Sep-25, Volume: 337, Issue:13 Topics: Amantadine; Antiviral Agents; Enzyme Inhibitors; Guanidines; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Neuraminidase; Pyrans; Rimantadine; Sialic Acids; Zanamivir	1997
Treating influenza with zanamivir. Management of Influenza in the Southern Hemisphere Trialists. Lancet (London, England), 1999, Feb-20, Volume: 353, Issue:9153 Topics: Administration, Inhalation; Amantadine; Antiviral Agents; Drug Resistance, Microbial; Guanidines; Humans; Influenza, Human; Orthomyxoviridae; Pyrans; Rimantadine; Sialic Acids; Time Factors; Zanamivir	1999
Flu-fighting options: decisions, decisions.... Health news (Waltham, Mass.), 2000, Volume: 6, Issue:12 Topics: Acetamides; Amantadine; Antiviral Agents; Guanidines; Humans; Influenza, Human; Oseltamivir; Pneumonia; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2000
ACIP releases guidelines on the prevention and control of influenza. Advisory Committee on Immunization Practices. American family physician, 2001, Oct-01, Volume: 64, Issue:7 Topics: Acetamides; Age Factors; Amantadine; Antiviral Agents; Drug Administration Schedule; Guanidines; Humans; Influenza Vaccines; Influenza, Human; Oseltamivir; Patient Selection; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2001
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 2002, Apr-12, Volume: 51, Issue:RR-3 Topics: Acetamides; Adolescent; Adult; Aged; Amantadine; Antiviral Agents; Child; Child, Preschool; Cost-Benefit Analysis; Guanidines; Humans; Infant; Influenza A virus; Influenza B virus; Influenza Vaccines; Influenza, Human; Middle Aged; Oseltamivir; Pyrans; Rimantadine; Risk Factors; Sialic Acids; United States; Vaccination; Zanamivir	2002
Development of a novel influenza A antiviral assay. Journal of virological methods, 2002, Volume: 105, Issue:1 Topics: Animals; Antiviral Agents; Branched DNA Signal Amplification Assay; Cell Line; Dogs; Guanidines; Humans; Influenza A virus; Influenza, Human; Microbial Sensitivity Tests; Nucleocapsid Proteins; Nucleoproteins; Oligonucleotide Probes; Pyrans; Rimantadine; RNA, Viral; Sialic Acids; Viral Core Proteins; Virus Replication; Zanamivir	2002
Economic analysis of influenza vaccination and antiviral treatment for healthy working adults. Annals of internal medicine, 2002, Aug-20, Volume: 137, Issue:4 Topics: Acetamides; Adolescent; Adult; Antiviral Agents; Computer Simulation; Cost of Illness; Cost-Benefit Analysis; Decision Trees; Drug Costs; Guanidines; Humans; Influenza Vaccines; Influenza, Human; Middle Aged; Oseltamivir; Pyrans; Rimantadine; Sensitivity and Specificity; Sialic Acids; Vaccination; Zanamivir	2002
Summaries for patients. Influenza vaccination or antiviral treatment for healthy working adults: an economic analysis. Annals of internal medicine, 2002, Aug-20, Volume: 137, Issue:4 Topics: Acetamides; Adolescent; Adult; Antiviral Agents; Computer Simulation; Cost of Illness; Cost-Benefit Analysis; Drug Costs; Guanidines; Humans; Influenza Vaccines; Influenza, Human; Middle Aged; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Vaccination; Zanamivir	2002
Current strategies for management of influenza in the elderly population. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Sep-15, Volume: 35, Issue:6 Topics: Acetamides; Aged; Aged, 80 and over; Chemoprevention; Complementary Therapies; Cost-Benefit Analysis; Disease Management; Guanidines; Health Services for the Aged; Humans; Influenza, Human; Institutionalization; Oseltamivir; Patient Compliance; Population Surveillance; Prevalence; Pyrans; Rimantadine; Sialic Acids; Vaccination; Zanamivir	2002
Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy. Annals of internal medicine, 2003, Sep-02, Volume: 139, Issue:5 Pt 1 Topics: Acetamides; Aged; Amantadine; Antiviral Agents; Computer Simulation; Cost-Benefit Analysis; Decision Support Techniques; Guanidines; Humans; Influenza, Human; Oseltamivir; Pyrans; Quality-Adjusted Life Years; Rimantadine; Sensitivity and Specificity; Sialic Acids; Zanamivir	2003
Summaries for patients. Cost-effective management of flu in adults older than 65 years of age. Annals of internal medicine, 2003, Sep-02, Volume: 139, Issue:5 Pt 1 Topics: Acetamides; Aged; Amantadine; Antiviral Agents; Computer Simulation; Cost-Benefit Analysis; Decision Support Techniques; Guanidines; Humans; Influenza, Human; Oseltamivir; Pyrans; Quality-Adjusted Life Years; Rimantadine; Sensitivity and Specificity; Sialic Acids; Zanamivir	2003
[Treatment of influenza in children]. Zhonghua er ke za zhi = Chinese journal of pediatrics, 2003, Volume: 41, Issue:2 Topics: Adamantane; Amantadine; Antiviral Agents; Child; Guanidines; Humans; Influenza, Human; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2003
Influenza infection of the embryonated hen's egg/an alternative model for in vivo evaluation of antiviral compounds. Arzneimittel-Forschung, 2004, Volume: 54, Issue:2 Topics: Amantadine; Animals; Antiviral Agents; Chick Embryo; Drug Evaluation, Preclinical; Guanidines; Influenza A virus; Orthomyxoviridae Infections; Pyrans; Rimantadine; Sialic Acids; Survival Analysis; Zanamivir	2004
Avian influenza should be ruffling our feathers. The Lancet. Infectious diseases, 2004, Volume: 4, Issue:10 Topics: Acetamides; Amantadine; Animals; Antiviral Agents; Asia, Eastern; Asia, Southeastern; Birds; Disease Outbreaks; Guanidines; Humans; Influenza in Birds; Influenza Vaccines; Influenza, Human; International Cooperation; Neuraminidase; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; World Health Organization; Zanamivir	2004
Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:12 Topics: Acetamides; Animals; Antiviral Agents; Cell Line; Cell Survival; Dogs; Drug Synergism; Enzyme Inhibitors; Guanidines; Influenza A virus; Neuraminidase; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Viral Plaque Assay; Virus Replication; Zanamivir	2004
Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors. Medical microbiology and immunology, 2006, Volume: 195, Issue:2 Topics: Acetamides; Amantadine; Animals; Antiviral Agents; Chick Embryo; Chickens; Enzyme Inhibitors; Guanidines; Influenza A virus; Influenza in Birds; Microbial Sensitivity Tests; Neuraminidase; Oseltamivir; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2006
Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005. Antiviral research, 2007, Volume: 73, Issue:2 Topics: Adamantane; Antiviral Agents; Australia; Drug Resistance, Viral; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A virus; Influenza, Human; Mutation; Neuraminidase; Oseltamivir; Phylogeny; Rimantadine; Zanamivir	2007
Antiviral management of seasonal and pandemic influenza. The Journal of infectious diseases, 2006, Nov-01, Volume: 194 Suppl 2 Topics: Amantadine; Animals; Antiviral Agents; Clinical Trials as Topic; Disease Outbreaks; Drug Resistance, Viral; Enzyme Inhibitors; Humans; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H5N1 Subtype; Influenza, Human; Mice; Neuraminidase; Oseltamivir; Rimantadine; Seasons; Zanamivir	2006
[Significance of virological diagnostics for the effective treatment of hospitalized patients infected with influenza virus]. Pneumonologia i alergologia polska, 2006, Volume: 74, Issue:2 Topics: Adult; Amantadine; Antiviral Agents; Diagnosis, Differential; Fluorescent Antibody Technique; Hospitalization; Humans; Influenza A virus; Influenza, Human; Middle Aged; Oseltamivir; Respiratory Tract Diseases; Reverse Transcriptase Polymerase Chain Reaction; Rimantadine; Treatment Outcome; Zanamivir	2006
Drug-induced linear immunoglobulin A bullous dermatosis mimicking Stevens-Johnson syndrome: a case report. Cutis, 2007, Volume: 79, Issue:3 Topics: Anti-Infective Agents; Autoimmune Diseases; Azithromycin; Diagnosis, Differential; Drug Eruptions; Fluorescent Antibody Technique, Direct; Humans; Immunoglobulin A; Male; Middle Aged; Rimantadine; Skin; Skin Diseases, Vesiculobullous; Stevens-Johnson Syndrome; Zanamivir	2007
Influenza. Canadian family physician Medecin de famille canadien, 2008, Volume: 54, Issue:3 Topics: Amantadine; Antiviral Agents; Humans; Influenza Vaccines; Influenza, Human; Mass Vaccination; Oseltamivir; Rimantadine; Zanamivir	2008
Antivirals and influenza: frequency of resistance. The Pediatric infectious disease journal, 2008, Volume: 27, Issue:10 Suppl Topics: Amantadine; Antiviral Agents; Disease Outbreaks; Drug Resistance, Viral; Humans; Influenza A virus; Influenza A Virus, H5N1 Subtype; Influenza B virus; Influenza, Human; Neuraminidase; Oseltamivir; Rimantadine; Zanamivir	2008
Detection of molecular markers of antiviral resistance in influenza A (H5N1) viruses using a pyrosequencing method. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:3 Topics: Amantadine; Animals; Antiviral Agents; Birds; Drug Resistance, Viral; Genetic Markers; Humans; Influenza A Virus, H5N1 Subtype; Influenza in Birds; Influenza, Human; Neuraminidase; Oseltamivir; Reverse Transcriptase Polymerase Chain Reaction; Rimantadine; RNA, Viral; Sensitivity and Specificity; Sequence Analysis, RNA; Zanamivir	2009
Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses. Drugs, 2009, Volume: 69, Issue:18 Topics: Cross Infection; Drug Resistance, Viral; Global Health; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H5N1 Subtype; Influenza B virus; Influenza Vaccines; Influenza, Human; Mutation; Neuraminidase; Oseltamivir; Population Surveillance; Rimantadine; Zanamivir	2009
Influenza antiviral prescribing practices during the 2007-08 and 2008-09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses. Antiviral research, 2010, Volume: 88, Issue:2 Topics: Adamantane; Antiviral Agents; Disease Outbreaks; Drug Resistance, Viral; Drug Utilization; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Oseltamivir; Practice Guidelines as Topic; Practice Patterns, Physicians'; Retrospective Studies; Rimantadine; Seasons; Surveys and Questionnaires; Zanamivir	2010
Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009. The Journal of infectious diseases, 2011, Dec-15, Volume: 204, Issue:12 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amantadine; Antiviral Agents; Drug Therapy, Combination; Female; Guideline Adherence; Hospitalization; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Middle Aged; Odds Ratio; Oseltamivir; Pandemics; Practice Guidelines as Topic; Practice Patterns, Physicians'; Pregnancy; Pregnancy Complications, Infectious; Rimantadine; United States; Young Adult; Zanamivir	2011
Site-directed M2 proton channel inhibitors enable synergistic combination therapy for rimantadine-resistant pandemic influenza. PLoS pathogens, 2020, Volume: 16, Issue:8 Topics: Antiviral Agents; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Rimantadine; Viral Matrix Proteins; Zanamivir	2020